The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajagopal, K.
Right arrow Articles by Bluestone, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajagopal, K.
Right arrow Articles by Bluestone, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/1999/12/1657/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 11, December 6, 1999 1657-1668


Original Article

RIBP, a Novel Rlk/Txk- and Itk-binding Adaptor Protein That Regulates T Cell Activation

Keshava Rajagopala, Connie L. Sommersb, Donna C. Deckerc, Elizabeth O. Mitchellc, Ulf Korthauerc, Anne I. Sperlinga,d, Christine A. Kozake, Paul E. Loveb, and Jeffrey A. Bluestonea,c
a Committee on Immunology, University of Chicago, Chicago, Illinois 60637
b Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
c Ben May Institute for Cancer Research, Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois 60637
d Department of Medicine, Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois 60637
e Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892

Correspondence to: Jeffrey A. Bluestone, Ben May Institute for Cancer Research, University of Chicago, MC 1089, 5482 South Maryland Ave., Chicago, IL 60637. Tel:773-702-0401 Fax:773-702-3701 E-mail:jbluest{at}immunology.uchicago.edu.

A novel T cell–specific adaptor protein, RIBP, was identified based on its ability to bind Rlk/Txk in a yeast two-hybrid screen of a mouse T cell lymphoma library. RIBP was also found to interact with a related member of the Tec family of tyrosine kinases, Itk. Expression of RIBP is restricted to T and natural killer cells and is upregulated substantially after T cell activation. RIBP-disrupted knockout mice displayed apparently normal T cell development. However, proliferation of RIBP-deficient T cells in response to T cell receptor (TCR)-mediated activation was significantly impaired. Furthermore, these activated T cells were defective in the production of interleukin (IL)-2 and interferon {gamma}, but not IL-4. These data suggest that RIBP plays an important role in TCR-mediated signal transduction pathways and that its binding to Itk and Rlk/Txk may regulate T cell differentiation.

Key Words: T cell activation, signal transduction, adaptor protein, Tec tyrosine kinases, T helper type 1/T helper type 2 cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS